Acumen Pharmaceuticals
ABOS
ABOS
80 hedge funds and large institutions have $176M invested in Acumen Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 22 increasing their positions, 24 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
80
Holders Change
+13
Holders Change %
+19.4%
% of All Funds
1.16%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
24
Increased
22
Reduced
24
Closed
11
Calls
$1.54M
Puts
$4.13M
Net Calls
-$2.59M
Net Calls Change
+$1.17M
Top Buyers
| 1 |
1
Fidelity Investments
Boston,
Massachusetts
|
$8.46M |
| 2 |
2
Millennium Management
New York
|
$10.6M |
| 3 |
3
T. Rowe Price Associates
Baltimore,
Maryland
|
$4.45M |
| 4 |
4
Alyeska Investment Group
Chicago,
Illinois
|
$3.81M |
| 5 |
5
Goldman Sachs
New York
|
$1.29M |
